Correlation Between ASPEN PHARUNADR and Guangzhou Baiyunshan
Can any of the company-specific risk be diversified away by investing in both ASPEN PHARUNADR and Guangzhou Baiyunshan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASPEN PHARUNADR and Guangzhou Baiyunshan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ASPEN PHARUNADR 1 and Guangzhou Baiyunshan Pharmaceutical, you can compare the effects of market volatilities on ASPEN PHARUNADR and Guangzhou Baiyunshan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASPEN PHARUNADR with a short position of Guangzhou Baiyunshan. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASPEN PHARUNADR and Guangzhou Baiyunshan.
Diversification Opportunities for ASPEN PHARUNADR and Guangzhou Baiyunshan
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ASPEN and Guangzhou is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding ASPEN PHARUNADR 1 and Guangzhou Baiyunshan Pharmaceu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guangzhou Baiyunshan and ASPEN PHARUNADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASPEN PHARUNADR 1 are associated (or correlated) with Guangzhou Baiyunshan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guangzhou Baiyunshan has no effect on the direction of ASPEN PHARUNADR i.e., ASPEN PHARUNADR and Guangzhou Baiyunshan go up and down completely randomly.
Pair Corralation between ASPEN PHARUNADR and Guangzhou Baiyunshan
Assuming the 90 days trading horizon ASPEN PHARUNADR 1 is expected to under-perform the Guangzhou Baiyunshan. But the stock apears to be less risky and, when comparing its historical volatility, ASPEN PHARUNADR 1 is 2.07 times less risky than Guangzhou Baiyunshan. The stock trades about -0.1 of its potential returns per unit of risk. The Guangzhou Baiyunshan Pharmaceutical is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 167.00 in Guangzhou Baiyunshan Pharmaceutical on September 26, 2024 and sell it today you would earn a total of 45.00 from holding Guangzhou Baiyunshan Pharmaceutical or generate 26.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ASPEN PHARUNADR 1 vs. Guangzhou Baiyunshan Pharmaceu
Performance |
| Timeline |
| ASPEN PHARUNADR 1 |
| Guangzhou Baiyunshan |
ASPEN PHARUNADR and Guangzhou Baiyunshan Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ASPEN PHARUNADR and Guangzhou Baiyunshan
The main advantage of trading using opposite ASPEN PHARUNADR and Guangzhou Baiyunshan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASPEN PHARUNADR position performs unexpectedly, Guangzhou Baiyunshan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guangzhou Baiyunshan will offset losses from the drop in Guangzhou Baiyunshan's long position.| ASPEN PHARUNADR vs. Merck Company | ASPEN PHARUNADR vs. Takeda Pharmaceutical | ASPEN PHARUNADR vs. HANSOH PHARMAC HD 00001 | ASPEN PHARUNADR vs. Guangzhou Baiyunshan Pharmaceutical |
| Guangzhou Baiyunshan vs. Merck Company | Guangzhou Baiyunshan vs. Takeda Pharmaceutical | Guangzhou Baiyunshan vs. HANSOH PHARMAC HD 00001 | Guangzhou Baiyunshan vs. ASPEN PHARUNADR 1 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |